Huxley R, Barzi F, Woodward M: Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006, 332 (7533): 73-78. 10.1136/bmj.38678.389583.7C.
Article
PubMed Central
PubMed
Google Scholar
Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M: Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1 c level. Diabetes Care. 2000, 23 (12): 1830-1834. 10.2337/diacare.23.12.1830.
Article
CAS
PubMed
Google Scholar
Miyazaki T, Shimada K, Iwama Y, Kume A, Sumiyoshi K, Sato Y, Ohmura H, Watanabe Y, Mokuno H, Daida H: Insulin response to oral glucose load is associated with coronary artery disease in subjects with normal glucose tolerance. J Atheroscler Thromb. 2008, 15 (1): 6-12. 10.5551/jat.E515.
Article
CAS
PubMed
Google Scholar
Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL: Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med. 2000, 342 (13): 905-912. 10.1056/NEJM200003303421301.
Article
CAS
PubMed
Google Scholar
Taylor EN, Hu FB, Curhan GC: Antihypertensive medications and the risk of incident type 2 diabetes. Diabetes Care. 2006, 29 (5): 1065-1070. 10.2337/dc05-2366.
Article
CAS
PubMed
Google Scholar
Sowers JR, Epstein M, Frohlich ED: Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001, 37 (4): 1053-1059.
Article
CAS
PubMed
Google Scholar
Elliott WJ, Meyer PM: Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007, 369 (9557): 201-207. 10.1016/S0140-6736(07)60108-1.
Article
CAS
PubMed
Google Scholar
Yoshinaga K, Iimura O, Abe K, Saruta T, Kurokawa K, Ishii M: A multicenter double-blind comparison study of CS-905 (azelnidipine) with nitrendipine in patients with essential hypertension. Journal of Clinical Therapeutic Medicine. 2000, 16: 671-739.
Google Scholar
Nishiya D, Enomoto S, Omura T, Matsumoto R, Kusuyama T, Izumi Y, Iwao H, Takeuchi K, Yoshiyama M: The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction. J Pharmacol Sci. 2007, 103 (4): 391-397. 10.1254/jphs.FP0061139.
Article
CAS
PubMed
Google Scholar
Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Inoue T, Node K: Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease. Am J Med Sci. 2007, 333 (6): 321-326. 10.1097/MAJ.0b013e318065c254.
Article
PubMed
Google Scholar
Kojima T, Miyauchi K, Yokoyama T, Yokoyama K, Kurata T, Suwa S, Kawamura M, Tamura H, Okazaki S, Inoue K: Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo University (ALPS-J). Circ J. 2011, 75 (5): 1071-1079. 10.1253/circj.CJ-11-0141.
Article
CAS
PubMed
Google Scholar
Yamagishi S, Inagaki Y, Nakamura K, Imaizumi T: Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties. J Cardiovasc Pharmacol. 2004, 43 (5): 724-730. 10.1097/00005344-200405000-00016.
Article
CAS
PubMed
Google Scholar
Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Koide H, Ueda Y, Takeuchi M, Yamagishi S: Calcium channel blocker inhibition of AGE and RAGE axis limits renal injury in nondiabetic patients with stage I or II chronic kidney disease. Clin Cardiol. 2011, 34 (6): 372-377. 10.1002/clc.20885.
Article
PubMed
Google Scholar
Iwai M, Li HS, Chen R, Shiuchi T, Wu L, Min LJ, Li JM, Tsuda M, Suzuki J, Tomono Y: Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan. J Pharmacol Exp Ther. 2006, 319 (3): 1081-1087. 10.1124/jpet.106.108894.
Article
CAS
PubMed
Google Scholar
Kain V, Kumar S, Puranik AS, Sitasawad SL: Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage. Cardiovasc Diabetol. 2010, 9: 82-10.1186/1475-2840-9-82.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009, 32 (1): 3-107.
CAS
PubMed
Google Scholar
Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int. 2010, 1: 2-20. 10.1007/s13340-010-0006-7.
Article
Google Scholar
Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM: Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum. 2008, 58 (4): 990-1000. 10.1002/art.23287.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bonetti PO, Pumper GM, Higano ST, Holmes DR, Kuvin JT, Lerman A: Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004, 44 (11): 2137-2141. 10.1016/j.jacc.2004.08.062.
Article
PubMed
Google Scholar
Gupta AK, Dahlof B, Dobson J, Sever PS, Wedel H, Poulter NR: Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication. Diabetes Care. 2008, 31 (5): 982-988. 10.2337/dc07-1768.
Article
CAS
PubMed
Google Scholar
Boilson BA, Kiernan TJ, Harbuzariu A, Nelson RE, Lerman A, Simari RD: Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med. 2008, 5 (8): 489-496. 10.1038/ncpcardio1277.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ogawa S, Mori T, Nako K, Ito S: Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy. Hypertens Res. 2008, 31 (6): 1147-1155. 10.1291/hypres.31.1147.
Article
CAS
PubMed
Google Scholar
Node K, Inoue T: Postprandial hyperglycemia as an etiological factor in vascular failure. Cardiovasc Diabetol. 2009, 8: 23-10.1186/1475-2840-8-23.
Article
PubMed Central
PubMed
Google Scholar
Boer-Martins L, Figueiredo VN, Demacq C, Martins LC, Consolin-Colombo F, Figueiredo MJ, Cannavan FP, Moreno H: Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients. Cardiovasc Diabetol. 2011, 10: 24-10.1186/1475-2840-10-24.
Article
PubMed Central
CAS
PubMed
Google Scholar
Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF: The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res. 2007, 48 (4): 751-762. 10.1194/jlr.R600021-JLR200.
Article
CAS
PubMed
Google Scholar
Matsui T, Yamagishi S, Nakamura K, Kikuchi S, Inoue H: Azelnidipine, a dihydropyridine-based calcium antagonist, inhibits angiotensin II-induced oxidative stress generation and downregulation of pigment epithelium-derived factor mRNA levels in microvascular endothelial cells. Drugs Exp Clin Res. 2005, 31 (5-6): 215-219.
CAS
PubMed
Google Scholar
Palatini P, Julius S: Heart rate and the cardiovascular risk. J Hypertens. 1997, 15 (1): 3-17. 10.1097/00004872-199715010-00001.
Article
CAS
PubMed
Google Scholar
Eguchi K, Kario K, Shimada K: Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients. Hypertens Res. 2002, 25 (3): 329-333. 10.1291/hypres.25.329.
Article
CAS
PubMed
Google Scholar
Nada T, Nomura M, Koshiba K, Kawano T, Mikawa J, Ito S: Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity. Arzneimittelforschung. 2007, 57 (11): 698-704.
CAS
PubMed
Google Scholar
Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003, 348 (7): 593-600. 10.1056/NEJMoa022287.
Article
PubMed
Google Scholar
Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I: The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996, 5 (3): 213-226. 10.1089/scd.1.1996.5.213.
Article
CAS
PubMed
Google Scholar
Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001, 104 (2): 191-196.
Article
CAS
PubMed
Google Scholar
Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, Pumper GM, Lerman LO, Lerman A: Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010, 31 (9): 1142-1148. 10.1093/eurheartj/ehq010.
Article
PubMed
Google Scholar
Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D: Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008, 57 (5): 1349-1354. 10.2337/db08-0063.
Article
CAS
PubMed
Google Scholar
Hiki M, Shimada K, Kiyanagi T, Fukao K, Hirose K, Ohsaka H, Fukushima Y, Kume A, Matsumori R, Sumiyoshi K: Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH). Circ J. 2010, 74 (7): 1471-1478. 10.1253/circj.CJ-10-0013.
Article
CAS
PubMed
Google Scholar
Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation. 2002, 106 (10): 1211-1218. 10.1161/01.CIR.0000027569.76671.A8.
Article
PubMed
Google Scholar